INMD

Inmode Ltd

14.20

Nov 04 • 3:59 PM ET +0.12 (0.85%)

14.20

Aftermarket • 4:15 PM ET 0.00 (0.00%)

Healthcare Medical Devices Israel Small NASD

Peers: APYX ESTA BHC CNMD EOLS ABBV SRTS SKIN IRIX AIRS

| Held by: IEFA SCZ IXUS IZRL EIS IDEV FNDC ITEQ SEIS GWX

Scroll to Statements

Index	-
Market Cap	817.13M
Enterprise Value	320.46M
Income	77.51M
Sales	374.62M
Book/sh	10.95
Cash/sh	8.71
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	660
IPO	Aug 08, 2019

P/E	11.52
Forward P/E	10.35
PEG	-
P/S	2.18
P/B	1.30
P/C	1.63
P/FCF	9.24
EV/EBITDA	4.59
EV/Sales	0.86
Quick Ratio	7.28
Current Ratio	8.18
Debt/Eq	0.01
LT Debt/Eq	0.01
Option/Short	Yes / Yes

EPS (ttm)	1.23
EPS next Y	1.37
EPS next Q	0.32
EPS this Y	-19.01%
EPS next Y	5.84%
EPS next 5Y	-3.28%
EPS past 3/5Y	-9.87% 6.62%
Sales past 3/5Y	-6.57% 12.44%
EPS Y/Y TTM	-50.25%
Sales Y/Y TTM	-6.71%
EPS Q/Q	-31.60%
Sales Q/Q	-0.01%
Earnings	Nov 11 BMO
EPS/Sales Surpr.	1.16% 0.74%

Insider Own	16.37%
Insider Trans	0.00%
Inst Own	52.24%
Inst Trans	-5.09%
ROA	10.85%
ROE	12.33%
ROIC	12.23%
Gross Margin	76.52%
Oper. Margin	18.47%
Profit Margin	20.69%
SMA20	1.68%
SMA50	-0.78%
SMA200	-0.90%
Trades

Shs Outstand	57.48M
Shs Float	48.12M
Short Float	4.61%
Short Ratio	4.63
Short Interest	2.22M
52W High	16.67 -14.82%
52W Low	12.72 11.64%
Volatility	3.31% 1.79%
ATR (14)	0.29
RSI (14)	54.67
Beta	1.95
Rel Volume	1.68
Avg Volume	479.43K
Volume	807,099

Perf Week	6.21%
Perf Month	1.50%
Perf Quarter	-6.08%
Perf Half Y	4.49%
Perf YTD	-3.34%
Perf Year	-2.94%
Perf 3Y	-33.89%
Perf 5Y	-85.23%
Perf 10Y	-
Recom	3.00
Target Price	16.17
Prev Close	14.08
Price	14.20
Change %	0.85%

Consensus

Hold

Avg. Price Target

$16.17

Implied Upside

+13.9%

Analysts7incl. previous ratings

Rating Distribution1 Buy · 6 Hold · 0 Sell

Date	Action	Analyst	Rating Change	Price Target Change	Implied Upside
Apr 29, 2025	Downgrade	BBTIG Research	Buy → Neutral
Apr 28, 2025	Downgrade	RRobert W. Baird	Outperform → Neutral	$22 → $16	+12.7%
Oct 17, 2024	Initiated	BBTIG Research	Buy	$25	+76.1%
Jul 23, 2024	Downgrade	JJefferies	Buy → Hold	$21 → $19	+33.8%
Nov 03, 2023	Downgrade	UUBS	Buy → Neutral	$52 → $24	+69.0%
Oct 13, 2023	Downgrade	CCanaccord Genuity	Buy → Hold	$55 → $22	+54.9%
Mar 29, 2023	Initiated	UUBS	Buy	$40	+181.7%
Feb 17, 2023	Downgrade	NNeedham	Buy → Hold
Dec 21, 2022	Initiated	BBarclays	Overweight	$44	+209.9%
Oct 12, 2022	Initiated	JJefferies	Buy	$40	+181.7%
May 25, 2021	Initiated	BBarclays	Overweight	$92	+547.9%
May 18, 2021	Initiated	NNeedham	Buy	$94	+562.0%
Sep 03, 2019	Initiated	UUBS	Buy	$28	+97.2%
Sep 03, 2019	Initiated	RRobert W. Baird	Outperform	$27	+90.1%
Sep 03, 2019	Initiated	CCanaccord Genuity	Buy	$30	+111.3%
Sep 03, 2019	Initiated	BBarclays	Overweight	$27	+90.1%

Oct-13-26 07:00AM	InMode to Report Third Quarter 2026 Financial Results on November 11, 2026, Expects Third Quarter Revenue of $91.8 Million to $92.0 Million, Reiterates FY 2026 Revenue Guidance Between $365M-$375M (PR Newswire)
Sep-09-26 08:05AM	InMode Advances RF Microneedling Comfort with the Launch of Morpheus8 Cool (PR Newswire)
Sep-01-26 11:37AM	A Wave of Weight-Loss Drugs Is Quietly Creating a Multi-Billion-Dollar Opportunity That Aesthetic Medicine Is Racing to Capture (PR Newswire)
Aug-05-26 07:20AM	InMode: Q2 Earnings Snapshot (Associated Press)
07:00AM	InMode Reports Second Quarter 2026 Financial Results: Quarterly GAAP Revenues of $95.6 Million, Consistent with the Second Quarter of 2025 (PR Newswire)
07:00AM	Loading…
Jul-13-26 07:00AM	InMode to Report Second Quarter 2026 Financial Results on August 5, 2026, Expects Q2 Revenue Between $95.2M-$95.4M, Reiterates FY 2026 Revenue Guidance Between $365M-$375M (PR Newswire)
Jul-09-26 09:59AM	InMode Shares Jump After Steel Partners Tables Higher Takeover Proposal (INMD) (InvestorsHub)
08:35AM	Steel Partners Offers to Acquire InMode for $16.75 Per Share in Cash (Business Wire)
Jun-26-26 08:25AM	DOMA PERPETUAL CAPITAL MANAGEMENT STRONGLY OPPOSES INMODE BUYOUT AS PROPOSED; PLANS TO VOTE AGAINST DEAL (PR Newswire)
Jun-24-26 03:14PM	Medical Aesthetics Play Flies On Unsolicited Takeover Bid; Why It Makes Sense (Investor's Business Daily) +10.79%
10:41AM	INMD Stock Heads For Best Day In Nearly Six Months How Does The Latest Takeover Proposal Compare To Steel Partners Offer? (Stocktwits)
08:40AM	InMode Confirms Receipt of Unsolicited Proposal (PR Newswire)
May-20-26 07:00AM	InMode Appoints Dr. Shlomo Nass as Chairman of the Board and Moshik Itzkovich as Chief Financial Officer (PR Newswire)
May-13-26 08:30AM	InMode to Present at Upcoming Investor Conferences and Events (PR Newswire)
May-06-26 07:09AM	InMode: Q1 Earnings Snapshot (Associated Press) -5.62%
07:00AM	Loading…
07:00AM	InMode Reports First Quarter 2026 Financial Results: Quarterly GAAP Revenue of $82 Million, Represents 5% Year-Over-Year Increase (PR Newswire)
Apr-13-26 07:00AM	InMode to Report First Quarter 2026 Financial Results and Hold Conference Call on May 6, 2026, Expects Q1 Revenue Between $81.5M-$81.7M, Reiterates FY 2026 Revenue Guidance Between $365M-$375M (PR Newswire)
Mar-24-26 08:30AM	InMode to Present at the 25th Annual Needham Virtual Healthcare Conference (PR Newswire)
Mar-13-26 07:00AM	InMode Announces New Share Repurchase Program (PR Newswire) +6.11%
Feb-26-26 08:00AM	InMode to Present at Upcoming Investor Conferences (PR Newswire)
Feb-23-26 10:32AM	InMode (INMD) Stock Slips As Board Ends Review (Benzinga) -6.70%
07:00AM	InMode Announces Conclusion of Independent Transaction Committee Review (PR Newswire)
Feb-10-26 04:02PM	InMode Ltd (INMD) Q4 2025 Earnings Call Highlights: Navigating Challenges with Strategic Growth ... (GuruFocus.com)
03:50PM	InMode Q4 Earnings Call Highlights (MarketBeat)
07:23AM	InMode: Q4 Earnings Snapshot (Associated Press Finance)
07:00AM	InMode Reports Fourth Quarter and Full Year 2025 Financial Results: Quarterly GAAP Revenue of $103.9 Million and Full Year Revenue of $370.5 Million (PR Newswire)
Feb-03-26 08:00AM	InMode to Participate in the 13th Annual BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference (PR Newswire)
Feb-02-26 07:00AM	InMode Responds to Transaction Rumors (PR Newswire) +5.79%
Jan-30-26 04:53PM	Deal Dispatch: Musk Merger Talk, LIV Golf Stakes, And A Flurry Of M&A From AI To Athleisure (Benzinga)
Jan-29-26 12:44PM	Steel Partners Targets InMode, Citing Stock Underperformance (Benzinga) +5.95%
05:30PM	Loading…
Jan-28-26 05:30PM	Steel Partners Holdings L.P. Announces It Has Presented $18.00 Per Share Offer for 51% of InMode Ltd. to Board of Directors (Business Wire)
Jan-26-26 03:34PM	InMode Flies To Three-Month High On A Rumored $1.1 Billion Takeover Offer (Investor's Business Daily) +10.61%
Jan-08-26 07:00AM	InMode to Report Fourth Quarter & Full Year 2025 Financial Results and Hold Conference Call on February 10, 2026, Expects Q4 Revenue Between $103.6M-$103.8M (PR Newswire) -8.82%
Nov-07-25 04:00AM	InMode Ltd (INMD) Q3 2025 Earnings Call Highlights: Global Expansion and Revenue Growth Amid ... (GuruFocus.com)
Nov-05-25 07:14AM	InMode: Q3 Earnings Snapshot (Associated Press Finance)
07:00AM	InMode Reports Third Quarter 2025 Financial Results: Quarterly Revenue of $93.2 Million, 78% Gross Margins (PR Newswire)
Nov-04-25 08:08AM	What To Expect From InMode Ltd (INMD) Q3 2025 Earnings (GuruFocus.com)
Nov-03-25 08:05AM	InMode Appoints Michael Dennison as President of North America (PR Newswire)
Oct-30-25 08:30AM	InMode to Participate in Upcoming Investor Conferences (PR Newswire)
Oct-09-25 07:00AM	InMode to Report Third Quarter 2025 Financial Results and Hold Conference Call on November 5, Expects Q3 Revenue Between $92.5M-$93.0M, Reiterates FY 2025 Guidance Between $365M-$375M (PR Newswire) +5.58%
Oct-07-25 05:39AM	Sanuwave Health (SNWV) Surges 9.1%: Is This an Indication of Further Gains? (Zacks)
Sep-09-25 08:15AM	DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Return Capital to the Shareholders (PR Newswire)
Sep-03-25 11:34AM	Do Options Traders Know Something About InMode Stock We Don't? (Zacks)
Sep-02-25 08:30AM	InMode to Present at Baird 2025 Global Healthcare Conference (PR Newswire)
Aug-05-25 08:30AM	InMode to Participate in Upcoming Investor Conferences (PR Newswire)
Jul-30-25 08:10AM	InMode (INMD) Q2 Earnings and Revenues Beat Estimates (Zacks)
07:08AM	InMode: Q2 Earnings Snapshot (Associated Press Finance)
07:00AM	InMode Reports Second Quarter 2025 Financial Results: Quarterly Revenue of $95.6 Million, 80% Gross Margins (PR Newswire)
Jul-29-25 09:51AM	What To Expect From InMode Ltd (INMD) Q2 2025 Earnings (GuruFocus.com)
Jul-25-25 10:31AM	Are Options Traders Betting on a Big Move in InMode Stock? (Zacks)
Jul-24-25 10:00AM	Envista (NVST) Earnings Expected to Grow: Should You Buy? (Zacks)
Jul-23-25 10:00AM	InMode (INMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Jul-16-25 09:39AM	Canaccord Genuity Maintains a Hold Rating on InMode Ltd. (INMD) (Insider Monkey)
Jul-10-25 07:00AM	InMode to Report Second Quarter 2025 Financial Results and Hold Conference Call on July 30, Expects Q2 Revenue Between $95.4M-$95.5M, Decreases Full Year 2025 Revenue Guidance to be Between $365M-$375M (PR Newswire)
May-28-25 08:30AM	InMode Response Letter to DOMA by Moshe Mizrahy, CEO, Dated May 28, 2025 (PR Newswire)
May-23-25 10:26AM	Do Options Traders Know Something About InMode Stock We Don't? (Zacks)
May-20-25 09:19AM	InMode Announces Health Canada Certification of the IgniteRF Platform with the New QuantumRF Technology (PR Newswire)
May-09-25 08:22AM	DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Resume Share Repurchase Program (PR Newswire)
May-07-25 08:30AM	InMode to Present at Upcoming Investor Conferences and Events (PR Newswire)
May-06-25 08:03AM	InMode Granted Injunction Against Counterfeit Sales of Morpheus8 Radio Frequency Microneedling Devices and Needle Cartridges (PR Newswire)
Apr-29-25 07:00AM	InMode Q1 Earnings: Short-Term Catalysts Have Vanished (Rating Downgrade) (Seeking Alpha)
05:57AM	Company News for Apr 29, 2025 (Zacks)
03:02AM	InMode Ltd (INMD) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... (GuruFocus.com)
01:52AM	InMode: Equity Value Hinges On Cash, Not Future Prospects (Rating Downgrade) (Seeking Alpha)
Apr-28-25 11:53AM	InMode Ltd. (INMD) Q1 2025 Earnings Call Transcript (Seeking Alpha) -12.08%
08:25AM	InMode (INMD) Lags Q1 Earnings Estimates (Zacks)
07:25AM	InMode: Q1 Earnings Snapshot (Associated Press Finance)
07:00AM	InMode Reports First Quarter 2025 Financial Results; Quarterly Revenue of $77.9 Million Represents 3% Year-Over-Year Decrease (PR Newswire)
Apr-24-25 10:01AM	Earnings Preview: Envista (NVST) Q1 Earnings Expected to Decline (Zacks)
Apr-21-25 10:00AM	Earnings Preview: InMode (INMD) Q1 Earnings Expected to Decline (Zacks)
Apr-14-25 07:00AM	InMode to Report First Quarter 2025 Financial Results and Hold Conference Call on April 28, 2025, Expects Q1 Revenue Between $77.2M-$77.5M, Reiterates FY 2025 Revenue Guidance Between $395M-$405M (PR Newswire)
Apr-10-25 11:36AM	InMode (INMD) Soars 6.8%: Is Further Upside Left in the Stock? (Zacks) -8.80%
Apr-03-25 04:26AM	InMode: Strategic Capital Allocation Unlocks Shareholder Value (Rating Upgrade) (Seeking Alpha) -9.34%
Mar-27-25 05:00AM	HCI Group and Boise Cascade have been highlighted as Zacks Bull and Bear of the Day (Zacks)
Mar-26-25 11:44AM	3 Undervalued MedTech Stocks to Buy for 2025 Gains Amid S&P 500 Rally (Zacks)
08:30AM	InMode to Present at the 24th Annual Needham Virtual Healthcare Conference (PR Newswire)
Mar-25-25 09:40AM	Is InMode (INMD) Stock Undervalued Right Now? (Zacks)
Mar-06-25 07:30AM	InMode Responds to Doma Perpetual's Letters (PR Newswire)
Mar-03-25 08:30AM	InMode to Present at Upcoming Investor Conferences (PR Newswire)
Feb-06-25 06:00PM	InMode (INMD) Q4 2024 Earnings Call Transcript (Motley Fool)
Feb-05-25 07:10AM	InMode Ltd (INMD) Q4 2024 Earnings Report Preview: What To Expect (GuruFocus.com)
02:08AM	InMode Ltd (INMD) Q4 2024 Earnings Call Highlights: Navigating Revenue Decline with Strategic ... (GuruFocus.com)
Feb-04-25 07:16AM	InMode: Q4 Earnings Snapshot (Associated Press Finance)
07:00AM	InMode Reports Fourth Quarter and Full Year 2024 Financial Results; Board of Directors Has Approved a New Share Repurchase Program (PR Newswire)
Feb-03-25 08:30AM	InMode to Participate in the BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference (PR Newswire)
Jan-29-25 09:48AM	Do Options Traders Know Something About InMode (INMD) Stock We Don't? (Zacks)
Jan-16-25 07:00AM	InMode to Report Fourth Quarter & Full Year 2024 and Hold Conference Call on February 4, 2025, Earlier than Originally Announced (PR Newswire)
Jan-15-25 08:05AM	DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Immediately Execute Tender Offer followed by Share Buyback (PR Newswire)
Jan-08-25 07:00AM	InMode to Report Fourth Quarter and Full Year 2024 Financial Results and Hold Conference Call on February 6, 2025, Expects Q4 Revenue Between $97.0M-$97.5M (PR Newswire) -7.99%
07:00AM	InMode to Report Fourth Quarter & Full Year 2024 Financial Results and Hold Conference Call on February 6, 2025, Expects Q4 Revenue Between $97.0M-$97.5M (PR Newswire)
Dec-10-24 10:53PM	Why Is InMode Ltd. (INMD) Among the Best Cosmetic Surgery and Aesthetics Stocks to Invest In Now? (Insider Monkey)
Nov-06-24 08:30AM	InMode to Present at Upcoming Investor Conferences (PR Newswire) +7.65%
Oct-31-24 07:29AM	InMode Sees Revenue Growth Amidst Challenges in Q3 2024 (TipRanks)
03:07AM	InMode Ltd (INMD) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic Adjustments (GuruFocus.com)
01:25AM	Q3 2024 Inmode Ltd Earnings Call (Thomson Reuters StreetEvents)
Oct-30-24 03:45PM	InMode (INMD) Q3 2024 Earnings Call Transcript (Motley Fool)
08:10AM	InMode (INMD) Q3 Earnings and Revenues Beat Estimates (Zacks)
07:07AM	InMode: Q3 Earnings Snapshot (Associated Press Finance)

Show Previous News

InMode Ltd. designs, develops, manufactures and markets minimally-invasive aesthetic medical products. It also designs, develops, manufactures and markets non-invasive medical aesthetic products that target a array of procedures including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture and superficial benign vascular and pigmented lesions. The company was founded by Moshe Mizrahy and Michael Kreindel on January 2, 2008 and is headquartered in Yokneam, Israel.

Co-FounderDr. Michael Kreindel Ph.D.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

INMD

Inmode Ltd

Upgrade your Finviz experience